Adverse events secondary to cetuximab therapy in head & neck cancer therapy and risk factors for serious outcomes

Stanbouly, D., Philipone, E., Morlandt, A. B., Kaleem, A., Chuang, S.-K., & Patel, N. (2022). Adverse events secondary to cetuximab therapy in head & neck cancer therapy and risk factors for serious outcomes. Oral Oncology, 131, 105952. https://doi.org/10.1016/j.oraloncology.2022.105952

Authors:

Dani Stanbouly

Elizabeth Philipone

Anthony B. Morlandt

Arshad Kaleem

Sung-Kiang Chuang

Neel Patel

Affiliated Authors:

Dani Stanbouly

Elizabeth Philipone

Columbia Affiliation: